Jun 13, 2022 / 08:20PM GMT
Nathan Allen Rich - Goldman Sachs Group, Inc., Research Division - Research Analyst
Good afternoon, everyone, and thank you so much for joining us. My name is Nathan Rich, and I cover the animal health space here at Goldman. We're very pleased to kick off our conference today with Zoetis. We have Wetteny Joseph, CFO; and Steve Frank for Investor Relations, live with all you. Unfortunately, for those of you in the room, you can see that I'm having to do this virtual. COVID threw a bit of a wrench in my plans, but I'm glad to have the opportunity to host virtually and my colleague [Chloe Segal] is on stage, who may jump in with some questions as well.
So Wetteny, thank you very much for joining us and glad that you are able to do this in person.
Wetteny N. Joseph - Zoetis Inc. - Executive VP & CFO
It's my pleasure, Nate. Thanks for having me.
Nathan Allen Rich - Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Before we jump in, we are required to make certain disclosures in public
Zoetis Inc at Goldman Sachs Global Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers